PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) 5-Year EBITDA Growth Rate : 4.60% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is PT Kalbe Farma Tbk 5-Year EBITDA Growth Rate?

PT Kalbe Farma Tbk's EBITDA per Share for the three months ended in Mar. 2024 was $0.38.

During the past 12 months, PT Kalbe Farma Tbk's average EBITDA Per Share Growth Rate was -13.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 0.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 4.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of PT Kalbe Farma Tbk was 21.10% per year. The lowest was 0.30% per year. And the median was 7.65% per year.

Competitive Comparison of PT Kalbe Farma Tbk's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Kalbe Farma Tbk's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's 5-Year EBITDA Growth Rate falls into.

PT Kalbe Farma Tbk 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

PT Kalbe Farma Tbk (OTCPK:PTKFY) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

PT Kalbe Farma Tbk 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFY) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

PTKFF:USA KLBF:Indonesia

Address

Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510

Website

https://www.kalbe.co.id

Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Headlines

No Headlines